论文部分内容阅读
目的评价热毒宁治疗小儿急性上呼吸道感染的临床疗效。方法将80例急性上呼吸道感染患儿随机分2组,平均每组40例,对照组儿科常规治疗,治疗组加用热毒宁注射液,结果对照组治愈率为67.6%,有效率为89.4%,治疗组治愈率为90.4%,有效率为96.8%;经统计学分析两者差异有统计学意义(P<0.05)。结论热毒宁治疗小儿急性上呼吸感染具有退热快,有效率高,不反弹,未见明显不良反应,安全性好,具有较好临床推广价值。
Objective To evaluate the clinical efficacy of Renduining in treating children with acute upper respiratory tract infection. Methods Eighty children with acute upper respiratory tract infection were randomly divided into two groups, with an average of 40 in each group. The control group received routine treatment of pediatric patients. The treatment group was treated with Rendunning injection. The results showed that the cure rate was 67.6% and the effective rate was 89.4 %, The treatment group cure rate was 90.4%, the effective rate was 96.8%; statistically significant difference between the two was statistically significant (P <0.05). Conclusion Rendunning treatment of children with acute upper respiratory infection with fever fast, high efficiency, no rebound, no obvious adverse reactions, good safety, and has good clinical value.